MediciNova, Inc. (MNOV)
1.79
+0.04
(+2.29%)
USD |
NASDAQ |
Sep 09, 13:40
MediciNova Price to Book Value : 2.364 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 2.311 |
| September 04, 2026 | 2.153 |
| September 03, 2026 | 2.139 |
| September 02, 2026 | 1.888 |
| September 01, 2026 | 1.902 |
| August 31, 2026 | 1.895 |
| August 28, 2026 | 1.895 |
| August 27, 2026 | 1.875 |
| August 26, 2026 | 1.954 |
| August 25, 2026 | 2.073 |
| August 24, 2026 | 2.021 |
| August 21, 2026 | 1.836 |
| August 20, 2026 | 1.809 |
| August 19, 2026 | 1.822 |
| August 18, 2026 | 1.770 |
| August 17, 2026 | 1.743 |
| August 14, 2026 | 1.73 |
| August 13, 2026 | 1.73 |
| August 12, 2026 | 1.756 |
| August 11, 2026 | 1.743 |
| August 10, 2026 | 1.743 |
| August 07, 2026 | 1.770 |
| August 06, 2026 | 1.796 |
| August 05, 2026 | 1.756 |
| August 04, 2026 | 1.717 |
| Date | Value |
|---|---|
| August 03, 2026 | 1.756 |
| July 31, 2026 | 1.756 |
| July 30, 2026 | 1.770 |
| July 29, 2026 | 1.704 |
| July 28, 2026 | 1.756 |
| July 27, 2026 | 1.743 |
| July 24, 2026 | 1.743 |
| July 23, 2026 | 1.73 |
| July 22, 2026 | 1.756 |
| July 21, 2026 | 1.756 |
| July 20, 2026 | 1.770 |
| July 17, 2026 | 1.783 |
| July 16, 2026 | 1.875 |
| July 15, 2026 | 1.849 |
| July 14, 2026 | 1.809 |
| July 13, 2026 | 1.796 |
| July 10, 2026 | 1.836 |
| July 09, 2026 | 1.822 |
| July 08, 2026 | 1.849 |
| July 07, 2026 | 1.902 |
| July 06, 2026 | 1.902 |
| July 02, 2026 | 1.888 |
| July 01, 2026 | 1.875 |
| June 30, 2026 | 1.743 |
| June 29, 2026 | 1.636 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.664 |
| Alnylam Pharmaceuticals, Inc. | 25.21 |
| Anika Therapeutics, Inc. | 2.036 |
| Savara, Inc. | 7.714 |
| Vericel Corp. | 5.368 |
Price to Book Value Related Metrics
| PS Ratio | 95.58 |
| Price | 1.79 |
| Earnings Yield | -12.22% |
| Market Cap | 88.11M |